Mammoth Biosciences Gets NIH Contract to Scale CRISPR Covid-19 Diagnostic Platform
Mammoth Biosciences’ Detectr test is the first CRISPR-based initiative to be funded by the RADx program.
Read MorePosted by Melanie Hamilton-Basich | Aug 4, 2020 | Covid 19, Uncategorized |
Mammoth Biosciences’ Detectr test is the first CRISPR-based initiative to be funded by the RADx program.
Read MorePosted by Laurie Bonner | Aug 2, 2020 | Covid 19, Uncategorized |
The two covid-19 serology tests display an estimated quantity of antibodies present in an individual’s blood resulting from a past infection with SARS-CoV-2.
Read MorePosted by Laurie Bonner | Aug 2, 2020 | Covid 19, Uncategorized |
An open-source software program from Zymo Research allows California laboratories to rapidly report covid-19 test data to CalREDIE.
Read MorePosted by Melanie Hamilton-Basich | Aug 1, 2020 | Covid 19 |
Researchers have developed a test that determines the amount of neutralizing antibodies against SARS-CoV-2 within 18 hours.
Read MorePosted by Melanie Hamilton-Basich | Aug 1, 2020 | Covid 19, Molecular Diagnostics |
FDA updated Molecular Diagnostic templates regarding diagnostic tests for use with sample pooling, at the point of care, and in detecting SARS-CoV-2.
Read More